NAS:TVTX (USA) Also Trade In: Germany
Travere Therapeutics Inc $ 26.95 0.61 (2.32%)
Warning! GuruFocus has detected 3 Severe warning signs with TVTX. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Travere Therapeutics Inc () from 2003 to Mar 05 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Travere Therapeutics stock (TVTX) PE ratio as of Mar 05 2021 is 0. More Details
Travere Therapeutics PE Ratio (TTM) Historical Data
View and export this data going back to 2003. Start your Free Trial
Travere Therapeutics PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:KALA NAS:CDXS NAS:ATRA NYSE:KDMN NAS:FIXX NAS:REPL NAS:MTEM NAS:AKRO NAS:MORF NAS:OYST OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 3611 Valley Centre Drive, Suite 300, San Diego, CA, USA, 92130
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases.